Home › Funds › Logos Global Management LP › QTTB
Logos Global Management LP position in QTTB
Q32 Bio Inc · Health Care
Logos Global Management LP reported holding 800,000 shares of QTTB (Q32 Bio Inc) in its Q2 2026 13F filing — a position valued at US$10.2M, representing 0.44% of its reported portfolio and ranking #48 among its reported holdings. Logos Global Management LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Logos Global Management LP's QTTB position evolved
Logos Global Management LP first disclosed a stake in QTTB in Q2 2026 at 800,000 shares (US$10.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 800.00K | $10.19M | New |
About QTTB and 13F data
QTTB (Q32 Bio Inc) is a Health Care company. 50 other funds we track also report a position in QTTB — the largest reported positions include ORBIMED ADVISORS LLC (US$52.6M), Boxer Capital Management, LLC (US$40.1M), Atlas Venture Life Science Advisors, LLC (US$34.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QTTB
- ORBIMED ADVISORS LLC 4.13M sh · $52.59M · Q2 2026
- Boxer Capital Management, LLC 3.15M sh · $40.12M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.72M sh · $34.62M · Q2 2026
- BVF INC/IL 2.35M sh · $29.94M · Q2 2026
- Opaleye Management Inc. 931.00K sh · $11.86M · Q2 2026
- Sanofi 244.08K sh · $3.11M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 216.17K sh · $2.75M · Q2 2026
- Carlyle Group Inc. 60.36K sh · $769.02K · Q2 2026
More on Logos Global Management LP
FAQ
How long has Logos Global Management LP held QTTB?
Logos Global Management LP has disclosed QTTB holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Logos Global Management LP's current position in QTTB?
As of Q2 2026, Logos Global Management LP holds 800.00K shares of QTTB (Q32 Bio Inc), valued at $10.19M, representing 0.44% of its reported portfolio and ranking #48.
Has Logos Global Management LP been buying or selling QTTB?
In the latest 13F filing (Q2 2026), Logos Global Management LP newly opened its position in QTTB.
Which other funds hold QTTB?
Other major institutional holders of QTTB include ORBIMED ADVISORS LLC, Boxer Capital Management, LLC, Atlas Venture Life Science Advisors, LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.